Washington Institute For Coagulation
98% goes to programs $0 to raise $100 Growing revenue
Washington Institute For Coagulation is a 501(c)(3) organization based in Seattle, Washington, registered in 2018, with $122,490,634 in FY2023 revenue. CharityIndex grades it A, and it directs about 98% of spending to programs.
701 Pike St Ste 1900, Seattle, WA, 98101 EIN 83-2302258 Since 2018
Revenue (FY2023)
$122.5M
▲ 7.0% vs prior year
Diseases median: $206K
Expenses (FY2023)
$108.9M
Net assets
$54.0M
Employees
43
CharityIndex rating
One independent A+ to F grade from four published criteria, each scored separately from IRS filings and combined by weight.
A
A+Program efficiency40% of the rating98% to programs · $0 to raise $100
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Washington Institute For Coagulation: 98% to programs · $0 to raise $100 earns a A+ on this criterion. See the exact thresholds →
AFinancial health25% of the rating6 mo reserves · +11% margin
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Washington Institute For Coagulation: 6 mo reserves · +11% margin earns a A on this criterion. See the exact thresholds →
AGovernance25% of the rating5 of 6 checks met
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Washington Institute For Coagulation: 5 of 6 checks met earns a A on this criterion. See the exact thresholds →
A+Transparency10% of the rating5 of 5 disclosure signals
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Washington Institute For Coagulation: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Mission
The washington center for bleeding disorders (wacbd) is dedicated to secure, promote and protect optimal health for people with bleeding disorders through comprehensive care, education and research in partnership with our patients, their families, and the local and national bleeding disorders community.
What they do
Pharmacy services: as an integral part of our comprehensive care model, our pharmacy provides blood clotting factor products to patients and hospital providers throughout the state of washingtonand parts of alaska, montana, and idaho. pharmacy services at the washington center for bleeding disorders (wacbd) has two primary components, a licensed hemophilia specialty pharmacy, and a licensed pharmaceutical wholesaler. the hemophilia specialty pharmacy supports clinical operations for more than 550 adult patients who receive care at our main facility in seattle, wa and at outreach clinics throughout the state of washington. the pharmacy also provides support to the more than 450 children with bleeding disorders who receive care at our affiliated children's centers located in tacoma, seattle, and spokane, washington. patient services are provided primarily through the filling of mail order prescriptions and patient counseling on factor and non-factor prescription medications for treatment of variety of bleeding disorders. the wholesale operations provide 24 hour a day/7 day a week support to wacbd clinical consultants and over 70 hospitals in washington state, who require blood factor replacement products and specialty pharmaceuticals for treatment of patients with bleeding disorders.
Contact & location
- Address
- 701 Pike St Ste 1900, Seattle, WA, 98101
- City
- Seattle
- State
- Washington
- Subcategory
- Other Diseases
- Phone
- …
- Website
- …
Financial trends
Revenue grew from $23.3M (FY2020) to $122.5M (FY2023) across 4 reported years.
Financial snapshot
Financial health & position (FY2023)
Liabilities $24.6MNet assets $54.0M
Operating margin
11.1%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$78.7M
Total liabilities
$24.6M
Net assets
$54.0M
Salaries & benefits
$8.0M
7% of expenses
Board members
5
4 independent
Financials by year
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2023 | $122,490,634▲7.0% | $108,898,367▲4.3% | $54,028,036▲33.6% | $78,674,468▲5.9% | 990 |
| 2022 | $114,481,287▲9.8% | $104,365,786▲8.9% | $40,434,846▲52.8% | $74,267,913▲18.7% | 990 |
| 2021 | $104,303,330▲348% | $95,835,264▲1701% | $26,459,150▲47.1% | $62,548,021▲172% | 990 |
| 2020 | $23,307,124 | $5,320,012 | $17,991,084 | $22,969,975 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Leadership & compensation (FY2023)
Highest-paid: Rebecca Kruse-jarres Md — $284,614 (0.26% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Rebecca Kruse-jarres Md | Executive/medical Director | 40 | $284,614 |
| Kim R Snyder | Chief Financial Officer/coo | 40 | $245,217 |
| Hsin Kai A Chen | Pharmacy Director | 40 | $164,615 |
| Heebeen Kim | Clinical Pharmacist | 40 | $145,592 |
| Catlin T Goodfriend | Clinical Pharmacist | 40 | $134,579 |
| Khoa C Le | Clinical Pharmacist | 40 | $134,401 |
| Renee M Killian | Clincial Nurse Coordinator | 40 | $128,294 |
| Anne Jezzamine Y Choi | Nurse Practitioner | 40 | $127,447 |
| Krishna Jafa | Treasurer | 1 | — |
| Kristian Prill Hamilton | President | 1 | — |
| Neil Josephson Md | Vice President | 1 | — |
| Roshni Kulkarni | Board Director | 1 | — |
Top vendors & contractors (FY2023)
| Contractor | Services | Paid |
|---|---|---|
| Dah Corporation DBA Isoutsource | It Contractors | $433,922 |
| Clark Nuber Ps | Accounting Services | $116,205 |
Grants received · $53K total
3 grants to Washington Institute For Coagulation totaling $53K, reported by foundations on their Schedule I filings.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Bloodworks | Von willibrand facotr in pregnancy (vip) study | 2023 | $17,948 |
| Bloodworks | Von willibrand facotr in pregnancy (vip) study | 2022 | $7,800 |
| Bloodworks | Von willebrand factor in pregnancy (vip) study | 2021 | $27,244 |
Similar organizations in Diseases
Diseases
Lifelong Health For All
Seattle, WA
$36.2M
Bannual revenue
Diseases
Provail
Seattle, WA
$28.0M
Bannual revenue
Diseases
Carol Milgard Breast Center
Tacoma, WA
$20.1M
Bannual revenue
Diseases
Peer Washington
Seattle, WA
$16.9M
Bannual revenue
Diseases
Saint John S Cancer Institute
Seattle, WA
$16.8M
Dannual revenue
Diseases
Shout It Now
Seattle, WA
$13.6M
Bannual revenue
Diseases
Alzheimers Disease Data Initiative Inc
Kirkland, WA
$12.5M
Dannual revenue
Diseases
Okanogan Behavioral Healthcare
Omak, WA
$11.5M
Bannual revenue
Diseases
Dave Purchase Project
Tacoma, WA
$11.4M
Bannual revenue
Diseases
Boyer Childrens Clinic
Seattle, WA
$10.6M
Bannual revenue
Compare Washington Institute For Coagulation
Frequently asked questions
- Is Washington Institute For Coagulation a legitimate nonprofit?
- Yes. Washington Institute For Coagulation is a 501(c)(3) organization registered with the U.S. Internal Revenue Service under EIN 83-2302258, based in Seattle, Washington. Donations are tax-deductible.
- What is Washington Institute For Coagulation's EIN?
- Washington Institute For Coagulation's Employer Identification Number (EIN) is 83-2302258.
- How much revenue does Washington Institute For Coagulation report?
- Washington Institute For Coagulation reported $122,490,634 in total revenue on its fiscal year 2023 IRS Form 990 filing.
- How much of Washington Institute For Coagulation's spending goes to programs?
- Washington Institute For Coagulation spends about 98% of its total expenses on programs, based on its latest IRS Form 990.
- What financial grade does Washington Institute For Coagulation have?
- CharityIndex grades Washington Institute For Coagulation A, based on program efficiency and fundraising cost.
- How much does Washington Institute For Coagulation's highest-paid employee make?
- The highest reported compensation on Washington Institute For Coagulation's latest Form 990 is $284,614, paid to Rebecca Kruse-jarres Md (Executive/medical Director).
More nonprofits in Seattle
Explore more
Data for Washington Institute For Coagulation (EIN 83-2302258) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.